<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29681099</article-id>
<article-id pub-id-type="pmc">5918269</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38675</article-id>
<article-id pub-id-type="manuscript">NIHMS951038</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>2016 CTF Conference on Neurofibromatosis Type 1, Neurofibromatosis Type 2 and Schwannomatosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fisher</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belzberg</surname>
<given-names>Allan J.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Blank</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Raedt</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elefteriou</surname>
<given-names>Florent</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferner</surname>
<given-names>Rosalie E.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giovannini</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harris</surname>
<given-names>Gordon J.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalamarides</surname>
<given-names>Michel</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karajannis</surname>
<given-names>Matthias A.</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Aerang</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lázaro</surname>
<given-names>Conxi</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Le</surname>
<given-names>Lu Q.</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Listernick</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Staci</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>Helen</given-names>
</name>
<xref ref-type="aff" rid="A17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pasmant</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="A18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ratner</surname>
<given-names>Nancy</given-names>
</name>
<xref ref-type="aff" rid="A19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schorry</surname>
<given-names>Elisabeth</given-names>
</name>
<xref ref-type="aff" rid="A20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ullrich</surname>
<given-names>Nicole J.</given-names>
</name>
<xref ref-type="aff" rid="A21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Viskochil</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiss</surname>
<given-names>Brian</given-names>
</name>
<xref ref-type="aff" rid="A23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Widemann</surname>
<given-names>Brigitte C.</given-names>
</name>
<xref ref-type="aff" rid="A24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="A25">25</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bakker</surname>
<given-names>Annette</given-names>
</name>
<xref ref-type="aff" rid="A26">26</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Serra</surname>
<given-names>Eduard</given-names>
</name>
<xref ref-type="aff" rid="A27">27</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Division of Oncology, Children’s Hospital of Philadelphia, and Department of Pediatrics, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA</aff>
<aff id="A2">
<label>2</label>Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, MD</aff>
<aff id="A3">
<label>3</label>Division of Oncology and Department of Pediatric, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH</aff>
<aff id="A4">
<label>4</label>Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA</aff>
<aff id="A5">
<label>5</label>Center for Skeletal Medicine and Biology, Dept. of Molecular and Human Genetics and Orthopedic Surgery, Baylor College of Medicine, Houston, TX</aff>
<aff id="A6">
<label>6</label>Neurofibromatosis Centre, Guy’s and St. Thomas NHS Foundation Trust London UK</aff>
<aff id="A7">
<label>7</label>Department of Head and Neck Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA</aff>
<aff id="A8">
<label>8</label>Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA</aff>
<aff id="A9">
<label>9</label>Department of Neurosurgery, Hospital Pitie-Salpetriere, AP-HP, Paris, France; Université Pierre et Marie Curie, Sorbonne Universités, Paris, France</aff>
<aff id="A10">
<label>10</label>Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
<aff id="A11">
<label>11</label>Division of Oncology, Children’s National Medical Center, Washington DC</aff>
<aff id="A12">
<label>12</label>Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-CIBERONC), L’Hospitalet de Llobregat, Barcelona, Spain</aff>
<aff id="A13">
<label>13</label>Department of Dermatology and Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX</aff>
<aff id="A14">
<label>14</label>Department of Pediatrics, Department of Biochemistry &amp; Molecular Biology, Penn State University College of Medicine, Hershey, PA</aff>
<aff id="A15">
<label>15</label>Division of Academic General Pediatrics, Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, and Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago IL</aff>
<aff id="A16">
<label>16</label>National Cancer Institute, National Institutes of Health, Bethesda, MD</aff>
<aff id="A17">
<label>17</label>Leibniz Institute on Aging Research, Fritz Lipmann Institute, Jena, 18. Germany</aff>
<aff id="A18">
<label>18</label>EA7331 and Cochin Hospital, Paris Descartes University, Faculty of Pharmacy of Paris, France</aff>
<aff id="A19">
<label>19</label>Division of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH</aff>
<aff id="A20">
<label>20</label>Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH</aff>
<aff id="A21">
<label>21</label>Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA</aff>
<aff id="A22">
<label>22</label>Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT</aff>
<aff id="A23">
<label>23</label>Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio</aff>
<aff id="A24">
<label>24</label>Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD</aff>
<aff id="A25">
<label>25</label>The Gilbert Family Neurofibromatosis Institute, Centers for Cancer and Immunology Research and Neuroscience Research, Children’s National Medical Center, Washington, DC</aff>
<aff id="A26">
<label>26</label>Children’s Tumor Foundation, New York, NY</aff>
<aff id="A27">
<label>27</label>Hereditary Cancer Group, The Institute for Health Science Research Germans Trias i Pujol (IGTP) – PMPPC, Barcelona, Spain</aff>
<author-notes>
<corresp id="FN1">Correspondence to: Michael J. Fisher, The Children’s Hospital of Philadelphia, Colket Translational Research Building - 10th Floor, 3501 Civic Center Blvd, Philadelphia, Pennsylvania 19104, Phone# (215)590-5188, Fax# (215)590-9956, <email>fisherm@email.chop.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>5</issue>
<fpage>1258</fpage>
<lpage>1269</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38675-->
<abstract>
<p id="P1">Organized and hosted by the Children’s Tumor Foundation (CTF), the Neurofibromatosis (NF) Conference is the premier annual gathering for clinicians and researchers interested in neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SWN). The 2016 edition constituted a blend of clinical and basic aspects of NF research that helped in clarifying different advances in the field. The incorporation of next generation sequencing is changing the way genetic diagnostics is performed for NF and related disorders, providing solutions to problems like genetic heterogeneity, overlapping clinical manifestations or the presence of mosaicism. The transformation from plexiform neurofibroma (PNF) to malignant peripheral nerve sheath tumor (MPNST) is being clarified, along with new management and treatments for benign and pre-malignant tumors. Promising new cellular and <italic>in vivo</italic> models for understanding the musculoskeletal abnormalities in NF1, the development of NF2 or SWN associated schwannomas, and clarifying the cells that give rise to NF1-associated optic pathway glioma were presented. The interaction of neurofibromin and S<italic>PRED1</italic> was described comprehensively, providing functional insight that will help in the interpretation of pathogenicity of certain missense variants identified in NF1 and Legius Syndrome patients. Novel promising imaging techniques are being developed, as well as new integrative and holistic management models for patients that take into account psychological, social and biological factors. Importantly, new therapeutic approaches for schwannomas, meningiomas, ependymomas, PNF, and MPNST are being pursued. This report highlights the major advances that were presented at the 2016 CTF NF Conference.</p>
</abstract>
<kwd-group>
<kwd>Neurofibromatosis</kwd>
<kwd>Schwannomatosis</kwd>
<kwd>Conference</kwd>
<kwd>Neurofibromin</kwd>
<kwd>Merlin</kwd>
<kwd>Neurofibroma</kwd>
<kwd>Malignant peripheral nerve sheath tumor</kwd>
<kwd>Schwannoma</kwd>
<kwd>Glioma</kwd>
<kwd>Ependymoma</kwd>
<kwd>Meningioma</kwd>
<kwd>Pseudoarthrosis</kwd>
<kwd>Autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>